Atracurium besylate is designated as 22carboxyethyl1,2, 3, 4tetrahydro6,7dimethoxy2methyl1veratrylisoquinolinium benzenesulfonate, pentamethylene ester. Atracurium besylate infusion solutions may be prepared by admixing atracurium besylate injection with an appropriate diluent such as 5% dextrose injection, 0. Jan 31, 2017 atracurium besilate injection should be used only by those skilled in the management of artificial respiration and only when facilities are immediately available for endotracheal intubation and for providing adequate ventilation support, including the administration of oxygen under positive pressure and the elimination of carbon dioxide. Atracurium 10 mgml solution for injection or infusion. Atracurium besylate injection atracurium besylate injection. Atracurium 10mgml solution for injection or infusion. Dbl atracurium besylate injection contains atracurium besylate as the active ingredient. Meitheal is an injectable drug company located in chicago, illinois. Atracurium besylate is indicated for induction of neuromuscular blockade, as an adjunct to general anesthesia, to facilitate endotracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Dailymed cisatracurium cisatracurium besylate injection. It can also be used to help with endotracheal intubation but suxamethonium succinylcholine is generally preferred if this needs to be done quickly.
Side effects of atracurium besylate injection atracurium. Our focus is building an extensive portfolio of drugs by bridging our global partner networks ability to supply high quality, yet affordable injectables to the us healthcare market. This drug should be used only by adequately trained individuals familiar with its actions, characteristics. Atracurium besilate 10 mgml solution for injection is administered by intravenous injection and must not be administered intramuscularly. After administration of a recommended initial bolus dose of atracurium besylate injection 0. Pharmacokinetics of atracurium besylate in the pig after a. Tracrium injection is a clear, faintly yellow, sterile, aqueous solution in a glass ampoule containing 10 mgml atracurium besylate. Atracurium besilate 10mgml solution for injection summary. Allergic reactions to atracurium or any component of the formulation. Atracurium besilate, also known as atracurium besylate, is a medication used in addition to other medications to provide skeletal muscle relaxation during surgery or mechanical ventilation.
A solid pharmaceutical composition comprising cisatracurium or a. Initially 300600 microgramskg, initial dose is optional, then by intravenous infusion 2701770 microgramskghour. Atracurium besylate is a complex molecule containing four sites at which different stereochemical configurations can occur. Initially 300600 microgramskg, then by intravenous injection 100200 microgramskg as required, alternatively by intravenous injection initially 300600 microgramskg, followed by by intravenous infusion 300600 microgramskghour. Drug interactions atracurium besylate is potentiated by isoflurane and by enflurane anaesthesia, and marginally potentiated by halothane see dosage and administration. Tracrium atracurium besylate injection is a sterile, nonpyrogenic aqueous solution. Dbl atracurium besylate injection atracurium besilate attracureeum consumer medicine information dbl atracurium besylate injection published by mims august 2019 1 what is in this leaflet please read this leaflet carefully before you are given dbl atracurium besylate injection atracurium.
Atracurium besylate injection usp generic formulation this drug should be used only by adequately trained individuals familiar with its actions, characteristics, and hazards. Find out what health conditions may be a health risk when taken with atracurium intravenous. Wo20189800a9 cisatracurium and betacyclodextrin derivative. Atracurium besylate injection, usp is a sterile, nonpyrogenic aqueous solution. Eu einecselincs list 2317912 cerclasara 3 emission reporting atracurium besylate. Atracurium is a nondepolarizing, intermediateduration, skeletal neuromuscular. Atracurium besylate is the generic ingredient in four branded drugs marketed by aurobindo pharma ltd, baxter hlthcare, baxter hlthcare corp, hospira, hospira inc, meitheal, mylan. However, we have demonstrated that separation of the main isomers of atracurium besylate. Lacks analgesic action and has no apparent effect on pain threshold, consciousness, or cerebration.
Atracurium besylate injection prescription and dosage sizes information for physicians and healthcare professionals. Atracurium is a nondepolarizing, intermediateduration, skeletal neuromuscular blocking agent. Atracurium indications, dosage, side effects and precautions. Nondepolarising agents antagonise the neurotransmitter action of acetylcholine by binding competitively with cholinergic receptor sites on the motor endplate. If you have any further questions, ask your doctor or pharmacist.
Upon removal from refrigeration to room temperature storage conditions 25c 77f, use atracurium besylate injection within 14 days even if rerefrigerated. Relaxation the dosage range recommended for adults is 0. Dbl atracurium besylate injection contains atracurium besilate 10 mg, in each ml. Mar 30, 2018 atracurium besylate injection should be refrigerated at 2 to 8c 36 to 46f to preserve potency. Summaries for consumers techniques of intrauterine fetal transfusion for women with red.
Cisatracurium pretreatment with tourniquet reduces propofol injection pain. Cisatracurium besylate is one of 10 isomers of atracurium besylate. Atracurium besylate injection is available in generic form. Cisatracurium besilate is a bisbenzyltetrahydroisoquinolinium that has effect as a. Severe allergic reactions including fatal anaphylactic reactions may occur. Chemical stability and adsorption of atracurium besylate. Atracurium besylate oel fastrac with ade affygility. Atracurium besylate all licensing, eu ctd dossiers. Webmd provides common contraindications for atracurium intravenous. A pharmacokinetic study of atracurium besylate was performed in the pig after a single i. This medication provides relaxation of skeletal muscles during surgery.
M2 pharmamay 21, 2012sagent pharmaceuticals inc unveils skeletal muscle relaxant drug atracurium besylate injection c2012 m2 communications. The plasma concentration values were obtained by high performance liquid chromatography. Page 1 of 38 commentary second supplement to usp 35nf 30. Indications and dosages adjunct to general anesthesia, to facilitate endotracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Atracurium by injection national library of medicine.
Atracurium besylate injection is a skeletal muscle relaxant used in addition to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Pharmaceutical form dbl atracurium besylate injection is a clear, colourless or faint yellow, sterile solution for injection. Atracurium besylate injection usp generic formulation. Cisatracurium besylate injection, usp is a sterile, nonpyrogenic aqueous solution provided in 5 ml, 10 ml, and 20 ml vials. Dbl atracurium besylate injection is a clear, colourless or faint yellow solution and comes in a glass ampoule. After induction agent, dose of neuromuscular blocking drug nmba atracurium. Cisatracurium besylate injection may be diluted to 0. Pdf impurity profiling and inprocess testing of drugs. Pharmacology, adverse reactions, warnings and side effects. Atracurium besylate injection, uspfor intravenous injection. The generic name cisatracurium was conceived by scientists at burroughs wellcome co. Impurity profiling and inprocess testing of drugs for. Atracurium besylate injection contains atracurium besilate 10 mg, in each ml. Atracurium besylate injection export data india with hs code.
Dbl atracurium besylate injection atracurium besilate attracureeum consumer medicine information dbl atracurium besylate injection published by mims august 2019 1 what is in this leaflet please read this leaflet carefully before you are given dbl atracurium besylate injection atracurium, even if you have had this medicine before. Benzenesulfonic acid water for injections this medicine does not contain. Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action. Discard unused portion of the 5 ml and 20 ml singledose vials. Rate of loss in potency increases to approximately 5% per month at 25c 77f. Atracurium besylate, a human prescription drug labeled by hospira, inc. Atracurium besylate injection is a solution containing atracurium besylate, an intermediateduration, nondepolarizing, skeletal muscle relaxant for intravenous. Atracurium besylate injection is a sterile solution containing not less than 90.
Atracurium medicines sps specialist pharmacy service. Find patient medical information for atracurium intravenous on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. If skin contact with the product formulation is likely, the use of latex or nitrile gloves is recommended. Atracurium besylate injection, usp, each ml containing 10 mg atracurium besylate is a sterile, nonpyrogenic, clear, colorless solution free from visible particles.
The 5 ml and 10 ml vials each contain cisatracurium besylate, equivalent to 2 mgml cisatracurium. Indian atracurium besylate injection export data covers valuable information for traders like bill of entry date, hs code, date of shipment, product description, indian exportport name, value and quantity of product. It has a role as a muscle relaxant and a nicotinic antagonist. Atracurium besylate injection page 6 of 19 between neuromuscular blocking agents has been reported in this class of drugs.
In the event of an inadvertent temperature excursion the following data may be used. The manufacturers of above mentioned scheduled formulations having maximum retail price higher than. Atracurium besylate oel fastrac with ade affygility solutions. Water for injection reach annex iv exemptions from the obligations of register. Drug name active ingredients strength dosage formroute marketing status te code rld rs. For continuous iv infusion, dilute atracurium besylate injection to the desired concentration usually 0. Canada vigilance program by one of the following 3 ways. The ndc code 0409110502 is assigned to atracurium besylate also known as. Atracurium besylate injection within 14 days even if rerefrigerated. Common side effects of atracurium besylate injection include. You can analyse the data and generate an analysis report like top exporters, buyers, and country of destination.
Inhibits neuromuscular transmission by binding competitively with acetylcholine to muscle end plate receptors. M is the concentration of atracurium besylate, in mg per ml, in the test preparation. Atracurium besylate ab is supplied as a sterile, nonpyrogenic aqueous solution for intravenous use. Atracurium besylate is indicated for induction of neuromuscular blockade, as an adjunct to general anesthesia, to facilitate endotracheal intubation, and to provide skeletal muscle relaxation during.
Sagent pharmaceuticals recalls atracurium besylate injection. Atracurium besylate, atracurium besylate manufacturers. Generic atracurium besylate inn entry, pharmaceutical. Using a twocompartment pharmacokinetic model, the elimination half life was found to be 28. Atracurium besylate injection atracurium besylate injection rxlist. The solution also contains benzenesulfonic acid to adjust the ph. The lyophilized preparation contains benzene sulfonic acid cisatracurium besylate and a lyophilization excipient, a weight ratio of the lyophilization excipient to the benzene sulfonic acid cisatracurium besylate. Atracurium besylate is an intermediateduration, nondepolarizing, skeletal muscle relaxant for intravenous administration. Atracurium atracurium besylate injection generic is a neuromuscularblocking agent, used as an adjuvant in anesthesia. Cisatracurium besylate injection, usp is a nondepolarizing skeletal muscle relaxant for intravenous administration. Nondepolarizing agents antagonize the neurotransmitter action of acetylcholine by binding competitively to cholinergic receptor.
Pronunciation a tra kyoo ree um therapeutic category. To address this issue, a program was initiated to investigate the individual isomer. Tracrium atracurium dosing, indications, interactions. Atracurium besylate drug information, uses, side effects. Atracurium is a diester compound consisting of pentane1,5diol with both hydroxyls bearing 3,4dimethoxybenzyl6,7dimethoxy2methyl3,4dihydroisoquinolinium21hylpropanoyl groups. Infusion solutions should be used within 24 hours of preparation. Atracurium definition of atracurium by medical dictionary. Atracurium drug monograph pediatric care online aap. Atracurium besilate 10 mgml solution for injection vial. To compare neuromuscular blockade and recovery characteristics of cisatracurium and atracurium in adult patients. Dbl atracurium besylate injection package contents shelf life.
Atracurium besilate injection should be used only by those skilled in the management of artificial respiration and only when facilities are immediately available for endotracheal intubation and for providing adequate ventilation support, including the administration of oxygen under positive pressure and the elimination of carbon dioxide. Dosage depends on anesthetic used, individual needs, and response. If you get any side effects, talk to your doctor or pharmacist. Children may need more frequent maintenance doses than adult. Testing drugs for injection by fast liquid chromatography 377. Chemical stability and adsorption of atracurium besylate injections in disposable plastic syringes. Atracurium besylate finished formulations export data. Atracurium besylate caspian tamin pharmaceutical company. Atracurium besilate drug bnf content published by nice. It contains an amount of the transtransisomer equivalent to not less than 5. Cisatracurium besylate injection is a colorless to slightly yellow or greenishyellow solution. The invention relates to a cisatracurium besylate lyophilized preparation composition stable at room temperature and a preparation method thereof. Given in general anesthesia only after unconsciousness has been induced by other drugs.
1004 1648 1405 1007 1204 425 818 1326 809 272 1083 481 664 925 1021 1103 1063 259 1673 134 425 467 36 272 741 394 149 695 1297 1107 30 1351 573